United StatesCongress
hr 7640Bill

To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

Introduced on May 3, 2022

House
Senate
President